Friday 6 November 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
335.33
4.35
−1.28%
Follow COR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
40.30 | 23.94 | 20.93 | 16.64 |
P/S ratio |
0.20 | 0.19 | 0.16 | 0.17 | |
P/FCF ratio |
17.97 | 38.15 | 13.31 | 14.76 | |
P/Operating CF |
(28.46) | 45.65 | 20.59 | 18.47 | |
P/B ratio |
31.30 | 17.05 | 16.87 | 17.69 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.22 | 0.22 | 0.19 | 0.19 | |
EV/EBITDA |
19.22 | 18.58 | 15.46 | 15.49 | |
EV/Operating CF |
16.73 | 31.34 | 13.19 | 13.29 | |
EV/FCF |
19.66 | 44.52 | 15.48 | 16.41 | |
Quick Ratio |
0.47 | 0.48 | 0.48 | 0.50 | |
Current Ratio |
0.92 | 0.95 | 0.93 | 0.94 | |
Net Debt/EBITDA |
6.02 | 7.26 | 6.37 | 0.00 | |
Debt/Assets |
10.11% | 15.17% | 13.99% | 12.93% | |
Debt/Equity |
3.78 | 3.45 | 3.62 | 3.06 | |
Asset Turnover |
4.42 | 4.30 | 4.22 | 4.12 | |
Operating CF/Net income |
(4.12) | 0.82 | 3.48 | 5.97 | |
Capex/Depreciation |
(0.29) | (0.63) | (0.81) | 0.00 | |
Interest Coverage |
10.50 | 8.13 | 7.96 | 6.65 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.09% | 2.52% | 2.52% | 2.46% | |
Intangible Assets out of Total Assets |
0.22 | 0.28 | 0.27 | 0.26 | |
Share Based Compensation of Revenue |
0.08% | 0.04% | 0.03% | 0.00% | |
Graham Net Nets |
(0.34) | (0.41) | (0.46) | (0.44) | |
Graham Number |
45.11 | 73.75 | 71.42 | 0.00 | |
Earnings Yield |
2.48% | 4.18% | 4.78% | 6.01% | |
Free Cash Flow Yield |
5.56% | 2.62% | 7.51% | 6.77% | |
Revenue per Share |
442.45 | 402.77 | 438.81 | 463.01 | |
Operating CF per Share |
(11.87) | 6.88 | 13.74 | 16.26 | |
Capex per Share |
(0.39) | (0.85) | (1.16) | (2.33) | |
Free Cash Flow per Share |
(12.26) | 6.03 | 12.58 | 13.93 | |
Cash per Share |
9.03 | 11.19 | 14.58 | 25.57 | |
Shareholders Equity per Share |
10.79 | 18.43 | 16.77 | 19.29 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.79 | 18.43 | 16.77 | 19.29 | |
Free Cash Flow |
(2,381.49) | 1,173.74 | 2,430.06 | 2,658.35 | |
Working Capital |
(4,980.57) | (2,991.38) | (3,861.96) | (3,929.33) | |
Capital Expenditures |
(76.32) | (164.90) | (224.00) | (444.28) | |
Net Current Asset Value |
(22,113.67) | (24,926.24) | (25,231.32) | (24,972.17) | |
EV/EBIT |
26.75 | 25.57 | 20.90 | 16.20 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Price to Operating Income |
24.45 | 21.91 | 17.97 | 14.58 | |
| Other line items | |||||
Average Receivables |
25,262.82 | 24,304.12 | 25,004.92 | 25,779.80 | |
Average Payables |
52,987.34 | 50,996.19 | 52,871.84 | 56,365.58 | |
Average Inventory |
22,293.26 | 19,487.76 | 20,584.10 | 20,927.99 | |
Average Assets |
73,707.76 | 76,422.99 | 78,881.23 | 81,847.55 | |
Average Common Equity |
1,228.93 | 2,382.38 | 2,724.49 | — |
Columns are period end dates · fundamentals updated 5 Nov 2026